Free Trial

Omron Corp. (OTCMKTS:OMRNY) Short Interest Update

Omron logo with Computer and Technology background

Key Points

  • Omron Corp. saw a significant increase in short interest in July, rising by 139.5% to a total of 37,600 shares, which represents approximately 0.0% of the company's shares.
  • GAMMA Investing LLC increased its stake in Omron by 180.8% during the 2nd quarter, now holding 1,488 shares valued at $40,000.
  • In its latest earnings report, Omron beat analysts' expectations with an EPS of $0.24 despite revenue slightly below forecasts at $1.29 billion.
  • Interested in Omron? Here are five stocks we like better.

Omron Corp. (OTCMKTS:OMRNY - Get Free Report) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totaling 37,600 shares, agrowthof139.5% from the July 15th total of 15,700 shares. Based on an average daily volume of 95,600 shares, the days-to-cover ratio is currently 0.4 days. Approximately0.0% of the shares of the company are short sold. Approximately0.0% of the shares of the company are short sold. Based on an average daily volume of 95,600 shares, the days-to-cover ratio is currently 0.4 days.

Hedge Funds Weigh In On Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC increased its position in shares of Omron Corp. (OTCMKTS:OMRNY - Free Report) by 180.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,488 shares of the company's stock after purchasing an additional 958 shares during the quarter. GAMMA Investing LLC's holdings in Omron were worth $40,000 at the end of the most recent reporting period. Institutional investors own 1.09% of the company's stock.

Omron Stock Performance

OMRNY traded down $0.5050 during trading hours on Thursday, hitting $25.5250. 35,672 shares of the stock were exchanged, compared to its average volume of 52,120. The stock has a 50-day simple moving average of $26.21 and a 200-day simple moving average of $27.98. Omron has a 12 month low of $24.1640 and a 12 month high of $47.7490. The stock has a market cap of $5.26 billion, a price-to-earnings ratio of 23.00 and a beta of 1.03. The company has a debt-to-equity ratio of 0.13, a current ratio of 2.31 and a quick ratio of 1.57.

Omron (OTCMKTS:OMRNY - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.05. Omron had a return on equity of 3.49% and a net margin of 4.04%.The firm had revenue of $1.29 billion for the quarter, compared to analysts' expectations of $1.31 billion. Analysts anticipate that Omron will post 0.42 earnings per share for the current year.

About Omron

(Get Free Report)

OMRON Corporation engages in industrial automation, device and module solutions, social systems, and healthcare businesses worldwide. The Industrial Automation Business offers sensors, switches, safety and control components, relays, motion and drives, robotics, energy conservation, power supplies, and automation system products.

Further Reading

Should You Invest $1,000 in Omron Right Now?

Before you consider Omron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omron wasn't on the list.

While Omron currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.